$
Federal Contract Award
Emergent Product Development Gaithersburg INC.
Department of Health and Human Services · April 26, 2024 · FY2024
HHSO100201700001CFull & OpenNAICS 541711
Obligated
$32,952,759
Contract details
- Award ID
- CONT_AWD_HHSO100201700001C_7505_-NONE-_-NONE-
- PIID
- HHSO100201700001C
- Period of performance
- September 15, 2017 → June 3, 2024
- Place of performance
- GAITHERSBURG, MD, USA
- Set-aside
- None (Full & Open)
- Pricing type
- COST PLUS FIXED FEE
- PSC
- AN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT
- NAICS
- 541711 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
Scope
IGF::OT::IGF - ADVANCING STABILIZED ISOAMYL NITRITE FOR INTRANASAL TREATMENT OF CYANIDE EXPOSURE
Parent vehicle (IDV)
Emergent Biosolutions INC.
UEI DKEFA8JAW3X4
This award was placed as a task/delivery order under a larger contract vehicle.
Recipient
Emergent Product Development Gaithersburg INC. →- UEI
- CNPVCR8DK7M8
- CAGE
- 057Y1
- Parent
- Emergent Biosolutions INC.
- Address
- GAITHERSBURG, MD
Awarding agency
Department of Health and Human Services →- Sub-agency
- Office of Assistant Secretary for Preparedness and Response
- Office
- BARDA - ASPR / DAAPPO / BARDA DCMA
- Funding agency
- Department of Health and Human Services
- Funding office
- BARDA - ASPR / DAAPPO / BARDA DCMA
See every contract Emergent Product Development Gaithersburg INC. has won
Full contracting history, year-over-year trends, subaward graph, and recompete alerts.
View Emergent Product Development Gaithersburg INC. profile →